Reported Dec 7, 2016 · Terminated

Indiomin MB URINARY ANTISEPTIC, ANTISPASMODIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium…

Burel Pharmaceuticals Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Burel Pharmaceuticals Inc · 199 Interstate Dr Ste N · Richland, MS · 39218-9433

Is this the product you have?

  • Indiomin MB URINARY ANTISEPTIC, ANTISPASMODIC Capsules
  • Each capsule contains
    • Methenamine 120 mg
    • Monobasic Sodium Phosphate 40.8 mg
    • Methylene Blue
    • 10 mg
    • Hyoscyamine Sulfate
    • 0.12 mg
    • 100 count
    • Rx only
  • Manufactured forBUREL PHARMACEUTICALS, NDC 35573-315-10
Lot codes and dates
    • LOT # 29401501
    • EXP 10/17
Amount recalled
795 bottles

This recall covers 8 products

The agency filed one notice per product. You are reading one of them; the other 7 are below.

Where it was sold

  • Nationwide

Why it was recalled

CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Burel Pharmaceuticals Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Aug 14, 2017 · Data as of Sep 19, 7:13 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.